In this special conversation from the New York Stock Exchange, Celiac Disease Foundation Chief Advancement Officer Brett Spitale and investment manager Gregg Stein discuss the growing momentum behind celiac disease awareness, research, and innovation. They explore how the Celiac Disease Foundation Impact Fund is helping accelerate progress by supporting promising technologies, therapies, and initiatives aimed at improving diagnosis, treatment, and ultimately finding a cure for celiac disease.